ARTICLE | Emerging Company Profile
Neoantigenics: Oocyte oversight
Neoantigenics is targeting oocyte-specific antigens to find, kill cancer cells
August 18, 2014 7:00 AM UTC
Neoantigenics LLC is developing cancer diagnostics and therapeutics based on oocyte-specific proteins that are re-expressed in some cancers. The goal is to create therapies with lower potential to cause side effects, including infertility.
For premenopausal women, many types of cancer treatment, such as chemotherapy, radiotherapy and hormonal treatments, can cause premature menopause or temporary or permanent infertility...